Skip to main content
Premium Trial:

Request an Annual Quote

Atlas Biolabs Named Roche NimbleGen CSP

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Roche NimgleGen today said that it has named Berlin, Germany-based Atlas Biolabs a certified service provider for the firm's SeqCap EZ enrichment product portfolio.

Atlas, which passed a certification process to qualify, will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture Array and solution-based capture workflow. The enriched samples can be analyzed afterward on the Roche GS FLX and GS Junior sequencing platforms, as well as on short-read sequencing platforms, said Roche.

Roche noted that its NimbleGen business recently launched a new addition to the SeqCap EZ product portfolio with SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube.

Last September, Roche had announced that Aliso Viejo, Calif.-based Ambry Genetics was named a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.